Literature DB >> 6769741

Nutritional management of patients with severe liver disease by using intravenous hyperalimentation and elemental diet.

A Watanabe, H Nagashima.   

Abstract

Management of protein-calorie malnutrition found in 32 patients with severe liver diseases such as fulminant hepatitis and cirrhosis of the liver was carried out using 2 types of synthetic amino acid solution (Hep-OU and Fischer solution) for intravenous and enteral alimentations with rapid monitoring of serum aminogram. Intravenous hyperalimentation of these cases resulted in maintenance of nutritional status with improvement of nitrogen balance and normalization of impaired serum aminogram. During this study, however, nutritional support was initiated only when intractable ascites, upper gastrointestinal bleeding and hepatic encephalopathy were observed. In 2 cases of fulminant hepatitis with sepsis and 3 hepatoma patients with ascites, elemental diet containing maltose and amino acids was used to supply sufficient amounts of nutrients in a minimum volume of water. These techniques with simultaneous monitoring of urinary excretion of 3-methylhistidine and creatinine height index as nutritional parameters make nutritional management easy for patients with liver disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769741     DOI: 10.1007/bf02774930

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  11 in total

1.  The electroencephalograph in liver disease.

Authors:  B G PARSONS-SMITH; W H SUMMERSKILL; A M DAWSON; S SHERLOCK
Journal:  Lancet       Date:  1957-11-02       Impact factor: 79.321

2.  [Serum amino acid imbalance and hepatic encephalopathy--nutritional therapy of severe liver diseases by infusion of branched chain amino acids (author's transl)].

Authors:  A Watanabe; T Higashi; H Nagashima; A Takesue
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1978-04

3.  [A rapid method for monitering serum neutral amino acid concentrations in severe liver diseases (author's transl)].

Authors:  A Watanabe; T Higashi; T Obata; S Hayashi; H Nagashima; A Baba; S Hayashi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1979-04

4.  The role of the branched-chain amino acids in decreasing muscle catabolism in vivo.

Authors:  H Freund; N Yoshimura; L Lunetta; J E Fischer
Journal:  Surgery       Date:  1978-06       Impact factor: 3.982

5.  The creatinine height index: its use in the estimation of the degree of protein depletion and repletion in protein calorie malnourished children.

Authors:  F E Viteri; J Alvarado
Journal:  Pediatrics       Date:  1970-11       Impact factor: 7.124

6.  Nutrition as an adjunct to cancer treatment in the adult.

Authors:  E M Copeland; J M Daly; S J Dudrick
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

Review 7.  Ntau-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview.

Authors:  V R Young; H N Munro
Journal:  Fed Proc       Date:  1978-07

8.  An approach to nutritional therapy of hepatic encephalopathy by normalization of deranged amino acid patterns in serum.

Authors:  A Watanabe; T Higashi; H Nagashima
Journal:  Acta Med Okayama       Date:  1978-12       Impact factor: 0.892

9.  Insulin, plasma aminoacid imbalance, and hepatic coma.

Authors:  H N Munro; J D Fernstrom; R J Wurtman
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

10.  Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.

Authors:  A R Smith; F Rossi-Fanelli; V Ziparo; J H James; B A Perelle; J E Fischer
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

View more
  2 in total

Review 1.  Parenteral nutrition: current status and concepts.

Authors:  G D Phillips; C L Odgers
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

2.  Characteristics change in serum amino acid levels in different types of hepatic encephalopathy.

Authors:  A Watanabe; S Hayashi; T Higashi; T Obata; T Sakata; N Takei; T Shiota; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.